Identification of Quality Markers for Tongmai Qiangshen Medicinal Liquor in the Treatment of Heart Failure Based on Multicomponent Qualitative–Quantitative Analysis and Integrated Bioinformatics
Biomedical Chromatography · 2026
DOI: 10.1002/bmc.70637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, 2026. Verfasst von Yuanyuan Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Heart Failure. Die Arbeit nennt 58 Literaturangaben.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) is an end stage of cardiovascular diseases. Tongmai Qiangshen Medicinal Liquor (TMQSJ) is an over‐the‐counter traditional Chinese medicinal liquor, but its efficacy‐related material basis and mechanisms in HF remain unclear. In this study, UPLC‐Q‐TOF‐MS/MS was used to characterize TMQSJ constituents and prototype compounds in rat plasma. HPLC fingerprinting, spectrum‐effect relationship analysis, single‐compound activity evaluation, and integrative bioinformatics were combined to screen efficacy‐related candidate quality markers and HF‐associated candidate genes. A total of 223 compounds were characterized, including 33 prototype plasma components. Chemometric analysis identified caffeic acid, Epimedin A, Epimedin B, Epimedin C, and icariin as characteristic constituents. Spectrum‐effect analysis based on 10 batches of TMQSJ and validation in DOX‐injured AC16 cells highlighted Epimedin A, Epimedin B, and Epimedin C. Among them, Epimedin A and Epimedin C showed prototype plasma exposure and were prioritized as efficacy‐related candidate quality markers. Integration of predicted targets of prototype plasma components with HF transcriptomic data and machine‐learning analysis identified BCL2L1, STAT3, HIF1A, MAPK8, and ESR1 as five candidate core genes. Immune cell estimation and molecular docking provided computational clues. Overall, this study establishes an integrated framework linking chemical quality, pharmacological association, in vivo exposure, and mechanistic prediction for TMQSJ quality evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, Liaoning, China.
- Professional Innovation Technology Center for Multidimensional Analysis of Traditional Chinese Medicine, Dalian, Liaoning, China.
- Liaoning Province Modern Chinese Medicine Research Engineering Laboratory, Dalian, Liaoning, China.
ORCID-Profile: Jinnan Huo, Shuai Wang, Yongrui Bao, Xiansheng Meng
Zitieren
APA
Li, Y., Huo, J., Zhang, Q., Li, T., Wang, S., Bao, Y., & Meng, X. (2026). Identification of Quality Markers for Tongmai Qiangshen Medicinal Liquor in the Treatment of Heart Failure Based on Multicomponent Qualitative–Quantitative Analysis and Integrated Bioinformatics. Biomedical Chromatography. https://doi.org/10.1002/bmc.70637
Vancouver
Li Y, Huo J, Zhang Q, Li T, Wang S, Bao Y, et al. Identification of Quality Markers for Tongmai Qiangshen Medicinal Liquor in the Treatment of Heart Failure Based on Multicomponent Qualitative–Quantitative Analysis and Integrated Bioinformatics. Biomedical Chromatography. 2026. doi:10.1002/bmc.70637
BibTeX
@article{Li2026,
author = {Li, Yuanyuan and Huo, Jinnan and Zhang, Qiang and Li, Tianjiao and Wang, Shuai and Bao, Yongrui and Meng, Xiansheng},
title = {Identification of Quality Markers for Tongmai Qiangshen Medicinal Liquor in the Treatment of Heart Failure Based on Multicomponent Qualitative–Quantitative Analysis and Integrated Bioinformatics},
journal = {Biomedical Chromatography},
year = {2026},
doi = {10.1002/bmc.70637}
}
EUVIMED